Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

LabiPatch Phyto

Labtec GmbH
Lip patch containing herbal ingredients for treamtent of Herpes labialis / cold sores

Mechanism of action

antiviral

Full description

Labtec has developed a revolutionary novel approach to treatment of Herpes labialis. LabiPatch® is specifically developed to adhere to the semi-moist environment of the lip and its surrounding skin. The patch is ultrathin and flexible. It contains two herbal ingredients with proven antiviral activity.

The patch is placed directly on the herpes outbreak. The moisture-sensitive polymer composition of the matrix allows easy application and gentle removal. Penetration pressure of the phytodrugs into the labial skin is high. Additionally the patch functions like an occlusive dressing, creating a moist environment which prevents crusting of the lesion and expedites wound healing significantly.

The product is a medical device type IIa. Marketing could start as early as Q1 2010

Development status

Preregistration

Patent information

Patent: pending

Type of business relationship sought

Labtec is seeking licensing partner(s) for clinical development and marketing

Licensing contact

Dr Ingo Lehrke
Managing Director; Business Development
Request more information

More information

For more information about the product please visit website.

Company details

Labtec GmbH
Labtec GmbH, an innovative pharmaceutical development company, focused on research and development of drug delivery systems, especially transdermal systems and fast dissolving oral films

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Research Partnership for Due Diligence Execution
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us